K944375

Substantially Equivalent

N/T RHEUMATOLOGY CONTROL SL/1, SL/2

Applicant: Behring Diagnostics, Inc.
Product code: DCK
Advisory panel: Immunology
Date received: 1994-09-07
Decision date: 1994-10-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Westwood, MA, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.